mDixon-Quant定量肾周及腹部脂肪对2型糖尿病早期肾功能改变的预测价值OA
Predictive value of mDixon-Quant-based quantification of perirenal and abdominal fat for early renal function changes in type 2 diabetes mellitus
目的 探讨应用mDixon-Quant技术定量肾周及腹部脂肪对2型糖尿病(T2DM)早期肾功能改变的预测价值.方法 前瞻性纳入T2DM病人75例,平均年龄(49.65±13.45)岁.根据尿白蛋白/肌酐比值(ACR)分为2组:正常白蛋白尿(NAU)组(44例)和微量白蛋白尿(MAU)组(31例).同期纳入41例年龄、性别相匹配的健康志愿者作为对照组.所有受试者行腹部mDixon-Quant序列扫描,测量双肾肾周脂肪厚度(PRFT)、内脏脂肪面积(VFA)及皮下脂肪面积(SFA).采用独立样本t检验、Mann-Whitney U检验进行2组间比较;单因素方差分析、Kruskal-Wallis检验、卡方检验进行 3 组间比较.采用Logistic回归分析T2DM早期肾功能改变的影响因素.Pearson或Spearman相关性分析总PRFT与临床特征之间的相关性.采用受试者操作特征(ROC)曲线分析总PRFT的预测效能,并计算其曲线下面积(AUC).结果 与对照组相比,NAU组及MAU组的体质量、体质量指数(BMI)、收缩压、舒张压、VFA、SFA、左肾PRFT(L-PRFT)、右肾PRFT(R-PRFT)、总PRFT均升高(均P<0.05);与NAU组相比,MAU组的肾小球滤过率(eGFR)、舒张压降低(均P<0.05),男性比例、收缩压、血清肌酐(SCr)、尿素/肌酐(UCR)升高(均P<0.05).多因素Logistic回归分析显示,舒张压和总PRFT是T2DM病人出现NAU状态的独立影响因素(P<0.05),且总PRFT在校正舒张压后仍是T2DM病人出现NAU状态的独立预测因素(P<0.05);总PRFT是影响T2DM病人出现MAU状态的独立影响因素(P<0.05).体质量、BMI与总PRFT呈正相关(r=0.642、0.616,均P<0.001).ROC曲线分析显示总PRFT预测NAU及MAU状态效能较高,其AUC值分别为0.822和0.810.结论 应用mDixon-Quant技术可无创、定量评价肾周及腹部脂肪,其中肾周脂肪对T2DM早期肾功能改变具有一定预测价值.
Objective To investigate the predictive value of quantitatively assessing perirenal and abdominal fat using the mDixon-Quant technique for early renal function changes in patients with type 2 diabetes mellitus(T2DM).Methods Seventy-five patients with T2DM(mean age,49.65±13.45 years)were prospectively enrolled.According to the urinary albumin creatinine ratio,patients were divided into a normal albuminuria(NAU)group(n=44)and a microalbuminuria(MAU)group(n=31).In addition,41 age-and sex-matched healthy volunteers were enrolled as a control group.All subjects underwent abdominal mDixon-Quant MRI scanning.Perirenal fat thickness(PRFT)of both kidneys,visceral fat area(VFA),and subcutaneous fat area(SFA)were measured.Independent sample t-test and Mann-Whitney U test were used for comparison between the two groups,while one-way analysis of variance,Kruskal-Wallis test,and chi-square test were used for comparison among three groups.Logistic regression analysis was applied to identify factors associated with early diabetic renal function changes.Pearson or Spearman correlation analyses were used to assess the relationships between total PRFT and clinical characteristics.Receiver operating characteristic(ROC)curve analysis was performed to evaluate the performance of total PRFT,and the area under the curve(AUC)was calculated.Results Compared with the control group,body weight,body mass index(BMI),systolic blood pressure,diastolic blood pressure,VFA,SFA,L-PRFT,R-PRFT,and total PRFT were significantly increased in both the NAU group and the MAU group(all P<0.05).Compared with the NAU group,the MAU groups showed significantly lower estimated glomerular filtration rate(eGFR)and diastolic blood pressure(both P<0.05),while the proportion of males,systolic blood pressure,serum creatinine(SCr),and urea-to-creatinine ratio(UCR)were significantly higher(all P<0.05).Multifactorial logistic regression analysis showed that diastolic blood pressure and total PRFT were independent associated with NAU status in patients with T2DM(P<0.05),and total PRFT remained an independent factor after adjusting diastolic blood pressure(P<0.05).Total PRFT was also an independent associated with MAU status in patients with T2DM(P<0.05).Body weight and BMI were positively correlated with total PRFT(r=0.642 and 0.616,respectively,both P<0.001).ROC curve analysis demonstrated that total PRFT had good predictive performance for NAU and MAU status,with AUC values of 0.822 and 0.810,respectively.Conclusions The mDixon-Quant technique enables noninvasive and quantitative assessment of perirenal and abdominal fat.Perirenal fat,in particular,shows predictive value for early renal function changes in patients with type 2 diabetes mellitus.
刘怡雯;张钰玲;马亚杰;李慧宇;季倩
天津医科大学第一中心医院,天津 300070天津市第一中心医院放射科江苏省苏北人民医院放射科天津市儿童医院影像科天津市第一中心医院放射科
医药卫生
磁共振成像水脂分离定量技术肾周脂肪糖尿病,2型肾功能
Magnetic resonance imagingQuantitative water-fat separation imagingPerirenal fatType 2 diabetes mellitusRenal function
《国际医学放射学杂志》 2026 (1)
22-28,95,8
天津市医学重点学科建设资助项目(TJYXZDXK-3-012B)天津市自然科学基金(21JCYBJC01050)天津市卫生健康科技项目(TJWJ2025ZD005)
评论